The prospective preventative HIV vaccine based on modified poliovirus

被引:0
|
作者
Zhang, Yang-de [1 ]
Lu, Xiao-lin [1 ]
Li, Nian-feng [1 ]
机构
[1] Cent S Univ, Inst Biomed Engn, Changsha 410008, Hunan, Peoples R China
关键词
D O I
10.1016/j.mehy.2006.07.062
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In order to control HIV pandemic, many vaccines are invented. Although none first verified its efficacy in clinic, we hypothesize that HIV vaccine based on poliovirus is potential to develop the promising one, because it can elicit the broad immune response including the main mucosal, humoral and cellular reaction. However, the viral neural virulence is one major concern. The attenuated Sabin strain is a better candidate. White partial poliovirus genes are replaced by HIV antigen genes, the defective interfering particle will fail to produce progeny virions, which may further ensure its security. Although the vaccinal immune efficacy was verified in some similar animal experiments based on poliovirus to express the exogenous genes, more animal and clinical immune trials about HIV-poliovirus chimeric minireplicons are to be carried out and the hypotheses are to be validated. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1258 / 1261
页数:4
相关论文
共 50 条
  • [21] Inactivated poliovirus vaccine
    Arya, Subhash C.
    Agarwal, Nirmala
    HUMAN VACCINES, 2007, 3 (03): : 71 - 72
  • [22] LIVE POLIOVIRUS VACCINE
    不详
    WORLD NEUROLOGY, 1961, 2 (03): : 262 - &
  • [23] STORAGE OF POLIOVIRUS VACCINE
    CHAO, J
    AMERICAN FAMILY PHYSICIAN, 1991, 44 (03) : 756 - &
  • [24] LIVE POLIOVIRUS VACCINE
    不详
    LANCET, 1960, 1 (MAY14): : 1057 - 1058
  • [25] ORAL POLIOVIRUS VACCINE
    MURRAY, R
    PUBLIC HEALTH REPORTS, 1976, 91 (01) : 89 - 90
  • [26] LIVE POLIOVIRUS VACCINE
    GARD, S
    ACTA PAEDIATRICA SCANDINAVICA, 1962, 51 (02): : 233 - &
  • [27] Poliovirus vaccine:: Commentary
    Olivé, JM
    Aylward, B
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1999, 77 (02) : 194 - 195
  • [28] Prospective inactivated or live poliovirus vaccine: effectiveness in the 21st Century
    Arya, Subhash C.
    Agarwal, Nirmala
    EXPERT REVIEW OF VACCINES, 2009, 8 (02) : 127 - 130
  • [29] FACTORS AFFECTING THE IMMUNOGENICITY OF ORAL POLIOVIRUS VACCINE - A PROSPECTIVE EVALUATION IN BRAZIL AND THE GAMBIA
    CIRNE, MD
    DUARTE, MNDR
    NOBREGA, DD
    DESOUZA, EMD
    MONTEIRO, D
    OLIVEIRA, MJC
    DANTAS, MCD
    CAVALCANTE, AMS
    BUENO, H
    FRANZOSI, I
    MENEZES, M
    RISI, JB
    BIELLIK, RJ
    GREENWOOD, BM
    HALL, AJ
    ROWE, M
    WELLS, J
    WHITTLE, H
    MBOGE, M
    GALAZKA, A
    ROBERTSON, SE
    SCOTT, RM
    WRIGHT, PF
    LINKINS, RW
    ORENSTEIN, WA
    PATRIARCA, PA
    ZELL, ER
    KEW, O
    MAHER, K
    PALLANSCH, M
    VANNOY, T
    JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05): : 1097 - 1106
  • [30] Performance of HIV Rapid and HIV ELISA Test Kits on Samples from a Preventative HIV Vaccine Trial to Evaluate Vaccine Induced Sero-Reactivity (VISR)
    Chetty, P.
    Stevens, G.
    Farah, B.
    Mwangi, I.
    Wangui, S.
    Schmidt, C.
    Laufer, D.
    Anzala, O.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A75 - A75